These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25935456)

  • 1. Ankylosis in ankylosing spondylitis: current concepts.
    Haroon N
    Clin Rheumatol; 2015 Jun; 34(6):1003-7. PubMed ID: 25935456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progression.
    Mauro D; Srinath A; Guggino G; Nicolaidou V; Raimondo S; Ellis JJ; Whyte J; Nicoletti MM; Romano M; Kenna TJ; Cañete JD; Alessandro R; Rizzo A; Brown MA; Horwood NJ; Haroon N; Ciccia F
    Clin Immunol; 2023 Jun; 251():109332. PubMed ID: 37075950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we stop progression of ankylosing spondylitis?
    Schett G; Rudwaleit M
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):363-71. PubMed ID: 20534370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
    Haynes KR; Pettit AR; Duan R; Tseng HW; Glant TT; Brown MA; Thomas GP
    Arthritis Res Ther; 2012 Nov; 14(6):R253. PubMed ID: 23171658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management.
    Magrey MN; Khan MA
    Curr Rheumatol Rep; 2017 Apr; 19(4):17. PubMed ID: 28361330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis.
    Klasen C; Meyer A; Wittekind PS; Waqué I; Nabhani S; Kofler DM
    Arthritis Res Ther; 2019 Jun; 21(1):159. PubMed ID: 31253169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of new bone formation and ankylosis in spondyloarthritis.
    Lories RJ; Schett G
    Rheum Dis Clin North Am; 2012 Aug; 38(3):555-67. PubMed ID: 23083755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis.
    Cortes A; Maksymowych WP; Wordsworth BP; Inman RD; Danoy P; Rahman P; Stone MA; Corr M; Gensler LS; Gladman D; Morgan A; Marzo-Ortega H; Ward MM; ; ; Learch TJ; Reveille JD; Brown MA; Weisman MH
    Ann Rheum Dis; 2015 Jul; 74(7):1387-93. PubMed ID: 24651623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bone morphogenetic proteins in ankylosing spondylitis.
    Carter S; Braem K; Lories RJ
    Ther Adv Musculoskelet Dis; 2012 Aug; 4(4):293-9. PubMed ID: 22859928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation Intensity-Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis.
    Li X; Wang J; Zhan Z; Li S; Zheng Z; Wang T; Zhang K; Pan H; Li Z; Zhang N; Liu H
    Arthritis Rheumatol; 2018 Jul; 70(7):1056-1070. PubMed ID: 29481736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies.
    Lories RJ; Haroon N
    Best Pract Res Clin Rheumatol; 2017 Dec; 31(6):877-886. PubMed ID: 30509446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Disease in Axial Spondyloarthritis.
    Van Mechelen M; Gulino GR; de Vlam K; Lories R
    Calcif Tissue Int; 2018 May; 102(5):547-558. PubMed ID: 29090349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?
    Neerinckx B; Lories RJ
    Curr Rheumatol Rep; 2017 Mar; 19(3):14. PubMed ID: 28265849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis.
    Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
    Arthritis Rheumatol; 2014 Nov; 66(11):2958-67. PubMed ID: 25047851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis.
    Zhang X; Aubin JE; Inman RD
    Curr Opin Rheumatol; 2003 Jul; 15(4):387-93. PubMed ID: 12819465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models.
    Braem K; Lories RJ
    Joint Bone Spine; 2012 May; 79(3):243-8. PubMed ID: 22079413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo.
    Braem K; Luyten FP; Lories RJ
    Ann Rheum Dis; 2012 May; 71(5):722-8. PubMed ID: 22121131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone formation in axial spondyloarthritis.
    Lories RJ; Haroon N
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):765-77. PubMed ID: 25488783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
    Tošovský M; Bradna P; Andrýs C; Andrýsová K; Cermáková E; Soukup T
    Acta Medica (Hradec Kralove); 2014; 57(2):56-61. PubMed ID: 25257151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in the Pathogenesis of Ankylosing Spondylitis and their Clinical Implication.
    Fu L; Wang G; Deng W; Lu Y
    Curr Mol Med; 2023; 23(10):1058-1065. PubMed ID: 36330642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.